Sector ratings Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 226.58 USD | -1.18% |
|
+0.99% | +13.59% |
| Jul. 20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| Jul. 13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 10.91B | AA | |||||||
| 46.86B | AAA | |||||||
| 40.23B | - | B | - | - | ||||
| 36.23B | - | |||||||
| 34.72B | AAA | |||||||
| 27.89B | A | |||||||
| 16.79B | BBB | |||||||
| 16.74B | - | - | - | - | ||||
| 13.12B | AA | |||||||
| 12.7B | AAA | |||||||
| 11.16B | AA | |||||||
| 11.07B | - | BBB | - | - | ||||
| 10.08B | - | B | - | - | ||||
| 9.49B | AA | |||||||
| 9.35B | - | A | - | - | ||||
| 9.1B | - | BBB | - | - | ||||
| 9.07B | - | B | - | - | ||||
| 8.82B | A | |||||||
| 8.75B | BB | - | ||||||
| 8.56B | AAA | |||||||
| Average | 17.58B | A | |||||||
| Weighted average by Cap. | A |
Select your edition
All financial news and data tailored to specific country editions
